Navigation Links
InspireMD Elects Two New Board Members
Date:8/11/2011

TEL-AVIV, Israel, Aug. 11, 2011 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced the election of two proven leaders to the Company's board of directors. Paul S. Stuka, Managing Member of Osiris Partners and a 30-year investment industry veteran, and Eyal Weinstein, a certified public accountant, former executive of several Israeli firms sold to larger companies and a director on the boards of several publicly traded companies, were both elected to InspireMD's Board of Directors. Both will be independent, non-executive directors.

Prior to forming Osiris Partners, Mr. Stuka was a Managing Director of Longwood Partners, managing small cap institutional accounts. In 1995, Mr. Stuka joined State Street Research and Management as manager of its Market Neutral and Mid Cap Growth Funds. From 1986 to 1994, Mr. Stuka served as the general partner of Stuka Associates, where he managed a U.S.-based investment partnership. Mr. Stuka began his career in 1980 as an analyst at Fidelity Management and Research. As an analyst, Mr. Stuka followed a wide array of industries including healthcare, energy, transportation, and lodging & gaming. Early in his career he became the assistant portfolio manager for three Fidelity Funds, including the Select Healthcare Fund, which was recognized as the top performing fund in the U.S. for the five-year period ending December 31, 1985. In 1984 he became the original manager of the Fidelity OTC Fund, which was the second-best performing U.S. mutual fund for 1985, appreciating 69%. At the time of his departure in June, 1986, the Fund had appreciated over 115% in 18 months and assets approached $1 billion. During his career, Mr. Stuka has been featured in articles in The Wall Street Journal, Bar
'/>"/>

SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
2. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
3. InspireMD Announces Year-to-Date 2011 Progress
4. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
5. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
8. InspireMD Boosts MGuard Production Capacity
9. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
10. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
11. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Tobramycin Market, 2010-2019" ... a traditional antibiotic whose eye drop and ointment are ... potential infection or inflammation caused by eye infection. Currently, ... are able to produce tobramycin, among which the Top ...
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Insulin Aspart Market, ... Developed by Novo Nordisk, insulin aspart (under the ... for the treatment of diabetes. Compared with human ... analog, starts working fast and reports higher peak ...
(Date:8/28/2015)... -- IP Shakti, LLC, today announced that it has changed its ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... signifies our transformation into a company focused on patent claim ... claim validity." ... platform, the Company commenced a corporate re-branding initiative in order ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
(Date:8/31/2015)... ... August 31, 2015 , ... “My mother and husband use oxygen ... Hagerhill, Ky. “I thought there could be a comfortable way to prevent the irritation, ... Cannula Ear Protector offers a more secure way to anchor the cannula tubing used ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... the nation’s medical professional association for physicians and allied health professionals dedicated ... Lifestyle Medicine Foundation, announced today the establishment of the Lifestyle Medicine Lifetime ...
(Date:8/31/2015)... ... August 31, 2015 , ... Chicago-based ... with Bright Pink® to raise money and awareness for breast and ovarian health. ... Hot Pink Sassy incandescent Mood-lite sold to Bright Pink® to encourage households, dorms, ...
(Date:8/31/2015)... FL (PRWEB) , ... August 31, 2015 , ... Juvent ... their growing list of major sports figures who are finding joint pain relief after ... and former #1 men’s tennis player in the world said, “For the first time ...
(Date:8/31/2015)... MA (PRWEB) , ... August 31, 2015 , ... Now ... Dietary Guidelines advice to "make at least half your grains whole,” with the majority ... Boston-based non-profit Oldways Whole Grains Council (WGC) released these findings and others ...
Breaking Medicine News(10 mins):Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5
... Inverness Medical Innovations, Inc. (Amex: IMA ... health management solutions, announced today that it will attend ... 12 through 15, 2009 at the Westin St. Francis ... Officer, and Jon Russell, Vice President, Finance, will attend. ...
... Ototoxicity , More cisplatin enters the inner ear ... explain why cisplatin treatment in humans can lead to ... of cisplatin a patient can tolerate is often limited ... as ototoxicity. Oxaliplatin is not frequently associated with the ...
... of,Florida,s proposed elimination of the Medicaid benefit that provides ... actually would cost,Florida millions more than the state currently ... reducing it - according to a newly released study,commissioned ... representing all of the state,s hospice providers. , ...
... adults and 19 percent of children taking chemotherapy drugs in ... or experienced other mistakes involving their medications, according to a ... of pediatrics at the University of Massachusetts Medical School, and ... Journal of Clinical Oncology . , "As cancer care continues ...
... Full recovery from an anterior cruciate ligament (ACL) reconstruction can be ... Utah published in the inaugural edition of Sports Health: A Multidisciplinary ... leg strength and lessen recovery issues. , ... Rosemont, ...
... American Scientific Resources, Inc. (Pink Sheets: ASFX), today announced the ... directors: Mr. Felix Reznick and Ms. Teresa McWilliams, American ... Boston College Law School and the New York ... Boston College Law School (J.D. 1998), and was ...
Cached Medicine News:Health News:Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009 2Health News:Also in the Dec. 30 JNCI 2Health News:Also in the Dec. 30 JNCI 3Health News:Cutting Medicaid Hospice Benefit Would Cost Florida More, Put Neediest Individuals at Risk 2Health News:Cutting Medicaid Hospice Benefit Would Cost Florida More, Put Neediest Individuals at Risk 3Health News:Errors involving medications common in outpatient cancer treatment 2Health News:Adding Eccentric Resistance Training Improves Muscle Strength Following ACL Surgery 2Health News:Adding Eccentric Resistance Training Improves Muscle Strength Following ACL Surgery 3Health News:American Scientific Resources Announces Addition of New Board Members 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: